Your search for bevacizumab returned 2 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Steve Duffy remove
Drugs in the Pipeline remove

Your search for bevacizumab returned 2 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Positive Top-Line Results for Ramucirumab in HCC Announced

REACH-2 was a randomized, double-blind, placebo-controlled trial that enrolled 292 patients with hepatocellular carcinoma (HCC) who were intolerant to, or had disease progression while on or following treatment with sorafenib and had a high alpha-fetoprotein (AFP-High) defined as AFP ≥400ng/mL.